[Current strategies against multi-drug resistant organisms]
- PMID: 26115132
- DOI: 10.1055/s-0041-102452
[Current strategies against multi-drug resistant organisms]
Abstract
The global spread of multi-drug resistant organisms (MDRO) is a major threat to public health. Fighting MDRO spread requires a multi-faceted approach as summarized in the German Antibiotic Resistance Strategy (DART). In the hospital, this includes antibiotic stewardship concepts and strict infection control measures. Treatment of MDRO is sophisticated. Within the last years, several antibiotics with activity against MRSA were launched and facilitate an individual therapy according to site of infection and co-morbidities. In contrast, novel antibiotics against carbapenemase producing Gram-negatives are still lacking. Current studies have shown, that a colistin-based combination treatment can improve the prognosis in these patients. The following article reviews MDRO definitions, burden of disease, treatment options and general strategies against MDRO.
© Georg Thieme Verlag KG Stuttgart · New York.
Similar articles
-
[Development of antimicrobial resistance in Germany : What is the current situation?].Med Klin Intensivmed Notfmed. 2017 Apr;112(3):186-191. doi: 10.1007/s00063-017-0272-2. Epub 2017 Apr 4. Med Klin Intensivmed Notfmed. 2017. PMID: 28378152 Review. German.
-
[Do we really need new antibiotics?].Dtsch Med Wochenschr. 2014 Nov;139 Suppl 3:S83-4. doi: 10.1055/s-0034-1369821. Epub 2014 Nov 27. Dtsch Med Wochenschr. 2014. PMID: 25429536 German. No abstract available.
-
[Multiresistant Organisms].Zentralbl Chir. 2015 Aug;140(4):417-25. doi: 10.1055/s-0032-1328343. Epub 2013 Jul 3. Zentralbl Chir. 2015. PMID: 23824619 Review. German.
-
Colistin: an antibiotic and its role in multiresistant Gram-negative infections.Acta Med Indones. 2015 Apr;47(2):157-68. Acta Med Indones. 2015. PMID: 26260559 Review.
-
[Multidrug-resistant organisms (MDRO) in patients in outpatient care in the Rhine-Main region, Germany, in 2014: Prevalence and risk factors].Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016 Feb;59(2):292-300. doi: 10.1007/s00103-015-2290-7. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016. PMID: 26631014 German.
Cited by
-
[Multidrug resistant bacteria in the intensive care unit : Reasonable measures for prevention].Med Klin Intensivmed Notfmed. 2016 Nov;111(8):743-754. doi: 10.1007/s00063-016-0223-3. Epub 2016 Oct 20. Med Klin Intensivmed Notfmed. 2016. PMID: 27766376 German.
-
[Antibiotic therapy of intra-abdominal infections in the era of multiresistance].Chirurg. 2016 Jan;87(1):26-33. doi: 10.1007/s00104-015-0106-9. Chirurg. 2016. PMID: 26577434 Review. German.
-
Calculated parenteral initial treatment of bacterial infections: Intra-abdominal infections.GMS Infect Dis. 2020 Mar 26;8:Doc13. doi: 10.3205/id000057. eCollection 2020. GMS Infect Dis. 2020. PMID: 32373438 Free PMC article.
-
Impact of the medical specialty on knowledge regarding multidrug-resistant organisms and strategies toward antimicrobial stewardship.Int Urol Nephrol. 2017 Aug;49(8):1311-1318. doi: 10.1007/s11255-017-1603-1. Epub 2017 Apr 21. Int Urol Nephrol. 2017. PMID: 28432607
-
Complication Rates After TRUS Guided Transrectal Systematic and MRI-Targeted Prostate Biopsies in a High-Risk Region for Antibiotic Resistances.Front Surg. 2020 Feb 28;7:7. doi: 10.3389/fsurg.2020.00007. eCollection 2020. Front Surg. 2020. PMID: 32185180 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical